Psychiatric issues in epilepsy: The complex relation of mood, anxiety disorders, and epilepsy

Epilepsy and Behavior

Volumn 15, Issue 1, 2009, Pages 83-87

  Kanner, Andres M ^a,b  

^a RUSH MEDICAL COLLEGE   (United States)

^b Laboratory of Electroencephalography and Video/EEG Telemetry   (United States)

Author keywords

Generalized anxiety disorder; Major depressive episode; Panic disorder; Serotonin; Temporal lobe epilepsy

Indexed keywords

ANTICONVULSIVE AGENT; CITALOPRAM; ESCITALOPRAM; FLUOXETINE; MIRTAZAPINE; PAROXETINE; PLACEBO; SEROTONIN; SEROTONIN 1A RECEPTOR; SERTRALINE; VENLAFAXINE;

ANXIETY DISORDER; ARTICLE; ATTENTION DEFICIT DISORDER; BRAIN SURGERY; CLINICAL TRIAL; COMORBIDITY; DEPRESSION; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE ASSOCIATION; DISEASE COURSE; EPILEPSY; GENERALIZED ANXIETY DISORDER; HUMAN; MOOD DISORDER; NONHUMAN; PANIC; PREVALENCE; QUALITY OF LIFE; RECEPTOR BINDING; RISK FACTOR; SEROTONIN RELEASE; SUICIDAL BEHAVIOR; SUICIDE ATTEMPT; TREATMENT OUTCOME;

AFFECT; ANXIETY; EPILEPSY; HUMANS; MENTAL DISORDERS; SUICIDE;

EID: 67349257453     PISSN: 15255050     EISSN: 15255069     Source Type: Journal    
DOI: 10.1016/j.yebeh.2009.02.034     Document Type: Article

References (47)

1. Téllez-Zenteno J.F., Matijevic S., and Wiebe S. Somatic comorbidity of epilepsy in the general population in Canada. Epilepsia 48 (2007) 2336-2344
2. Pellock J.M. Managing behavioral and cognitive problems in children with epilepsy. J Child Neurol Suppl. 1 (2004) S73-S74
3. Lewis A. Melancholia: a historical review. J Ment Sci 80 (1934) 1-42
4. Forsgren L., and Nystrom L. An incident case - referent study of epileptic seizures in adults. Epilepsy Res 6 (1990) 66-81
5. Hesdorffer D.C., Hauser W.A., Annegers J.F., et al. Major depression is a risk factor for seizures in older adults. Ann Neurol 47 (2000) 246-249
6. Hesdorffer D.C., Hauser W.A., Olafsson E., Ludvigsson P., and Kjartansson O. Depression and suicidal attempt as risk factor for incidental unprovoked seizures. Ann Neurol 59 (2006) 35-41
7. Austin J.K., Harezlak J., Dunn D.W., Huster G.A., Rose D.F., and Ambrosius W.T. Behavior problems in children before first recognized seizures. Pediatrics 107 (2001) 115-122
8. Austin J.K., Dunn D.W., Caffrey H.M., Perkins S.M., Harezlak J., and Rose D.F. Recurrent seizures and behavior problems in children with first recognized seizures: a prospective study. Epilepsia 43 (2002) 1564-1573
9. Jones J.E., Watson R., Sheth R., et al. Psychiatric comorbidity in children with new onset epilepsy. Dev Med Child Neurol 49 (2007) 493-497
10. McAfee A.T., Chilcott K.E., Johannes C.B., Hornbuckle K., Hauser W.A., and Walker A.M. The incidence of first unprovoked seizure in pediatric patients with and without psychiatric diagnoses. Epilepsia 48 (2007) 1075-1082
11. Alper K., Schwartz K.A., Kolts R.L., and Khan A. Seizure incidence in psychopharmacological clinical trials: an analysis of Food and Drug Administration (FDA) summary basis of approval reports. Biol Psychiatry 62 (2007) 345-354
12. Dobson K.S., and Cheung E. Relationship between anxiety and depression: conceptual and methodological issues. In: Maser J.D., and Cloninger C.R. (Eds). Comorbidity of mood and anxiety disorders (1990), American Psychiatric Press, Washington, DC
13. Merikangas K.R., and Angst J. Comorbidity and social phobia: evidence from clinical, epidemiologic and genetic studies. Eur Arch Psychiatry Clin Neurosci 244 (1995) 297-303
14. Zung W.W.K., Magruder-Habib K., Velez R., and Alling W. The comorbidity of anxiety and depression in general medical patients: a longitudinal study. J Clin Psychiatry 51 Suppl. 6 (1990) 77-80
15. Kanner A.M., Wuu J., Barry J., Hermann B., Meador K.J., and Gilliam F. Atypical depressive episodes in epilepsy: a study of their clinical characteristics and impact on quality of life. Neurology 62 Suppl. 5 (2004) A249
16. Lehrner J., Kalchmayr R., Serles W., et al. Health-related quality of life (HRQOL), activity of daily living (ADL) and depressive mood disorder in temporal lobe epilepsy patients. Seizure 8 (1999) 88-92
17. Perrine K., Hermann B.P., Meador K.J., et al. The relationship of neuropsychological functioning to quality of life in epilepsy [see comments]. Arch Neurol 52 (1995) 997-1003
18. Gilliam F., Kuzniecky R., Faught E., et al. Patient-validated content of epilepsy-specific quality-of-life measurement. Epilepsia 38 (1997) 233-236
19. Boylan L.S., Flint L.A., Labovitz D.L., Jackson S.C., Starner K., and Devinsky O. Depression but not seizure frequency predicts quality of life in treatment-resistant epilepsy. Neurology 62 (2004) 258-261
20. Cramer J.A., Blum M., Reed M., Fanning K., and and the Epilepsy Impact Project. The influence of comorbid depression on quality of life for people with epilepsy. Epilepsy Behav 4 (2003) 515-521
21. Johnson E.K., Jones J.E., Seidenberg M., and Hermann B.P. The relative impact of anxiety, depression, and clinical seizure features on health-related quality of life in epilepsy. Epilepsia 45 (2004) 544-550
22. Kanner AM, Gilliam FG, Hermann B, Meador KJ. Differential effect of mood and anxiety disorders on the quality of life and perception of adverse events to antiepileptic drugs in patients with epilepsy. In: Abstracts from the 2007 Annual Meeting of the American Epilepsy Society. Epilepsia 2007;48(Suppl. 6):1-118.
23. Cramer J.A., Blum D., Fanning K., Reed M., and and the Epilepsy Impact Project Group. The impact of comorbid depression on health resource utilization in a community sample of people with epilepsy. Epilepsy Behav 5 (2004) 337-342
24. U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research, Office of Translational Sciences, Office of Biostatistics. Statistical review and evaluation: antiepileptic drugs and suicidality. May 21, 2008.
25. Hesdorffer DC, Kanner AM. The FDA alert on suicidality and antiepileptic drugs: fire or false alarm? Epilepsia, in press.
26. Jones J.E., Hermann B.P., Barry J.J., Gilliam F.G., Kanner A.M., and Meador K.J. Rates and risk factors for suicide, suicidal ideation, and suicide attempts in chronic epilepsy. Epilepsy Behav 4 (2003) S31-S38
27. Christensen J., Vestergaard M., Mortensen P., Sidenius P., and Agerbo E. Epilepsy and risk of suicide: a population-based case-control study. Lancet Neurol 6 (2007) 693-698
28. Harris E.C., and Barraclough B. Suicide as an outcome for mental disorders: a meta-analysis. Arch Neurol 46 (1989) 1065-1068
29. Nilsson L., Ahlbom A., Farahmand B.Y., Asberg M., and Tomson T. Risk factors for suicide in epilepsy: a case control study. Epilepsia 43 (2002) 644-651
30. Hitiris N., Mohanraj R., Norrie J., Sills G.J., and Brodie M.J. Predictors of pharmacoresistant epilepsy. Epilepsy Res 75 (2007) 192-196
31. Kanner AM, Byrne RW, Chicharro AV, Wuu J, Frey M. Is a lifetime psychiatric history predictive of a worse postsurgical seizure outcome following a temporal lobectomy? Neurology, 2009;72:793-9.
32. Anhoury S., Brown R.J., Krishnamoorthy E.S., and Trimble M.R. Psychiatric outcome after temporal lobectomy: a predictive study. Epilepsia 41 (2000) 1608-1615
33. Jobe P.C., and Weber R.H. Affective disorder and epilepsy comorbidity in the genetically epilepsy prone-rat (GEPR). In: Gilliam F., Kanner A.M., and Sheline Y.L. (Eds). Depression and brain dysfunction (2006), Taylor & Francis, London 121-158
34. Dailey J.W., Mishra P.K., Ko K.H., Penny J.E., and Jobe P.C. Serotonergic abnormalities in the central nervous system of seizure-naive genetically epilepsy-prone rats. Life Sci 50 (1992) 319-326
35. Yan Q.S., Jobe P.C., and Dailey J.W. Evidence that a serotonergic mechanism is involved in the anticonvulsant effect of fluoxetine in genetically epilepsy-prone rats. Eur J Pharmacol 252 (1993) 105-112
36. Beck S.G., and Choi K.C. 5-Hydroxytryptamine hyperpolartizes CA3 hippocampal pyramidal cells through an increase in potassium conductance. Neurosci Lett 133 (1991) 93-96
37. Toczek M.T., Carson R.E., Lang L., et al. PET imaging of 5-HT1A receptor binding in patients with temporal lobe epilepsy. Neurology 60 (2003) 749-756
38. Savic I., Lindstrom P., Gulyas B., Halldin C., Andree B., and Farde L. Limbic reductions of 5-HT1A receptor binding in human temporal lobe epilepsy. Neurology 62 (2004) 1343-1351
39. 18F]MPPF-PET study. Brain 127 (2004) 900-913
40. Hasler G., Bonwetsch R., Giovacchini G., et al. 5-HT(1A) receptor binding in temporal lobe epilepsy patients with and without major depression. Biol Psychiatry 62 (2007) 1258-1264
41. 11C]WAY-100635: effects of depression and antidepressant treatment. Arch Gen Psychiatry 57 (2000) 174-180
42. Drevets W.C., Frank E., Price J.C., et al. PET imaging of serotonin 1A receptor binding in depression. Biol Psychiatry 46 (1999) 1375-1387
43. Cheetham S.C., Crompton M.R., Katona C.L., and Horton R.W. Brain 5-HT1 binding sites in depressed suicides. Psychopharmacology 102 (1990) 544-548
44. Charney D.S., and Bremner J.D. The neurobiology of anxiety disorders. In: Charney D.S., and Nestler E.J. (Eds). Neurobiology of mental illness. 2nd ed. (2004), Oxford Univ. Press, New York 605-627
45. Neumeister A., Bain E., Nugent A.C., et al. Reduced serotonin type 1A receptor binding in panic disorder. J Neurosci 24 (2004) 589-591
46. Gilliam F.G., Barry J.J., Hermann B.P., Meador K.J., Vahle V., and Kanner A.M. Rapid detection of major depression in epilepsy: a multicentre study. Lancet Neurol 5 (2006) 399-405
47. Kroenke K., Spitzer R.L., Williams J.B., Monahan P.O., and Löwe B. Anxiety disorders in primary care: prevalence, impairment, comorbidity, and detection. Ann Intern Med 146 (2007) 317-325